24
Participants
Start Date
November 30, 2015
Primary Completion Date
October 4, 2016
Study Completion Date
October 4, 2016
MSC2364447C
Subjects will be administered with MSC2364447C 25 milligrams orally once daily for 4 weeks.
MSC2364447C
Subjects will be administered with MSC2364447C 75 milligrams orally once daily for 4 weeks.
Placebo
Subjects will be administered with placebo matching to MSC2364447C orally once daily for 4 weeks.
Research site, Sofia
Research site, Sofia
Research site, Sofia
Research site, DeBary
Research site, Orlando
Research site, Clearwater
Research site, Anniston
Research site, Grand Blanc
Research site, St Louis
Research site, Austin
Research site, Los Angeles
Research site, Lakewood
Research site, El Cajon
Merck KGaA, Darmstadt, Germany
INDUSTRY
EMD Serono Research & Development Institute, Inc.
INDUSTRY